Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.
Sponsor: Emergent BioSolutions
Summary
The goal of this observational study is to evaluate the safety and clinical benefit of two doses of CYFENDUS vaccine when used with the concurrent recommended antibacterial regimen for post-exposure prophylaxis to prevent inhalational anthrax and/or anthrax meningitis.
Official title: A Phase 4 Retrospective Observational Study of CYFENDUS™ Anthrax Vaccine Among Individuals Who Received Post-Exposure Prophylaxis Vaccination During a Bacillus Anthracis Mass Exposure Event
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2035-11
Completion Date
2037-11
Last Updated
2025-12-08
Healthy Volunteers
No
Conditions
Interventions
CYFENDUS
Intramuscular administration of two doses of Anthrax Vaccine Adsorbed, Adjuvanted